- Executive Breakfast at Analytica 2022
June 22, 2022
7:30 am - 9:00 am EST
June 22, 2022
Restaurant “Kafër am See” (Seeblick section) at The New Munich Trade Fair Centre
7:30 AM (CEST) Breakfast
8:05 AM Presentation
9:00 AM Adjournment
The breakfast presents a great opportunity to meet and network with other senior executives from our members and invited guests attending Analytica 2022.
In addition to presenting a great opportunity to meet and network with other ALDA member executives and a few key membership prospects attending Analytica, we also invite a guest speaker.
Prof. dr. John W. A. Rossen, a Medical Molecular Microbiologist at LMMI Isala, Zwolle, The Netherlands will be our speaker. Professor Dr. Rossen is also an Associate Professor, Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Groningen, The Netherlands and an Adjunct Professor, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA. He started as a medical molecular microbiologist at the Laboratory for Medical Microbiology and Infectious Diseases (LMMI) Isala in October 2021. His focus is to further power science and medicine to improve health by decoding the unknown, including setting the standard for identifying and understanding microorganisms and their role in human disease and public health.
Professor Dr. Rossen has a 30-year history in Molecular Virology and Microbiology and published more than 200 peer-reviewed articles. He obtained a Bachelor of Science in Mathematics & Physics at Utrecht University and a Master of Science in Biology at Utrecht University as well. In 1996, he obtained a PhD in (Molecular) Virology and Cell Biology at the Faculty of Veterinary Medicine, Utrecht University. His PhD research focused on “Coronavirus – Host Interactions.” Since 2004, next to his (fundamental) research, he is actively involved in Molecular Diagnostics and Prevention of Infectious Diseases. As a Professor for Personalized Microbiology, he successfully implemented the use of Next-Generation Sequencing for routine Clinical Microbiology and Infection Prevention. Nowadays, he and his research group focus on applying metagenomics and metatranscriptomics into Clinical Microbiology and Public Health.